Regional and National Events 2012

This presentation identifies and explains some of the key challenges and issues in RnD project portfolio management within the pharmaceutical industry, including conflicting objectives, poor information management, and a lack of understanding of basic concepts such as risk and uncertainty. A bold new vision is presented for a fully integrated, strategic approach to RnD project portfolio management that can be applied to all industries.

About the speaker:

Dr. Kelvin Stott has over 15 years of experience in R&D
project and portfolio management, strategy, innovation, risk
and performance management in the pharma/biotech industry.
After his PhD and a Fellowship at Cambridge, Kelvin began
his career as a management consultant at McKinsey, advising
top pharma companies on their R&D productivity. He founded
UK biotech company Senexis and managed the company's R&D
pipeline as CSO, and then managed biotech investments for a
billion Euro VC fund, before joining Merck Serono as Head of
Divisional Performance Management. Then as Head of
Portfolio Management and BI Systems, he led critical
initiatives to de-risk the company's global R&D pipeline and
improve its project portfolio risk management systems, tools
and processes across the organization. Kelvin now works as
an independent consultant, advising pharma/biotech companies
on R&D project portfolio management, innovation, risk and
performance management. Check Dr Stott's Linkedin profile

Agenda

18:00 Registration

18:30 Presentation

19:30 Q and A until 19:45

20:00 Apero and Networking

About PMI Switzerland Chapter Regional Event Committee:

This event is organized and run by the Regional Event Committee Romandie, a group of PMI Swiss Chapter Volunteers. Are you interested to join us? Learn more click here for volunteering opportunities.